Jejunal tube extensions via percutaneous endoscopic gastrostomy and delayed small-bowel perforations: a case series
- 31 March 2012
- journal article
- case report
- Published by Elsevier BV in Gastrointestinal Endoscopy
- Vol. 75 (3), 683-687
- https://doi.org/10.1016/j.gie.2011.10.009
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS Wild-Type Metastatic Colorectal CancerClinical Colorectal Cancer, 2012
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerBritish Journal of Cancer, 2011
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With CetuximabJAMA, 2010
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisThe Lancet Oncology, 2010
- Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximabEuropean Journal of Cancer, 2010
- KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancerBritish Journal of Cancer, 2009
- Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancerBritish Journal of Cancer, 2009
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerThe New England Journal of Medicine, 2009
- The validity of the Royal College of Pathologists’ colorectal cancer minimum dataset within a populationBritish Journal of Cancer, 2007
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001